Passage Bio (PASG) Competitors

Procaps Group (NASDAQ:PROC) and Passage Bio (NASDAQ:PASG) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, media sentiment, institutional ownership, community ranking and earnings.

Which has stronger earnings and valuation, PROC or PASG?

Procaps Group has higher revenue and earnings than Passage Bio.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Procaps Group	$409.92M	0.26	$42.54M	N/A	N/A
Passage Bio	N/A	N/A	-$102.06M	-$1.02	-0.38

Is PROC or PASG more profitable?

Procaps Group's return on equity of 0.00% beat Passage Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Procaps Group	N/A	N/A	N/A
Passage Bio	N/A	-72.53%	-52.10%

Do insiders & institutionals believe in PROC or PASG?

53.5% of Passage Bio shares are held by institutional investors. 19.9% of Procaps Group shares are held by insiders. Comparatively, 5.0% of Passage Bio shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Do analysts rate PROC or PASG?

Passage Bio has a consensus target price of $7.50, suggesting a potential upside of 1,818.16%. Given Passage Bio's stronger consensus rating and higher probable upside, analysts plainly believe Passage Bio is more favorable than Procaps Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Procaps Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Passage Bio	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more risk and volatility, PROC or PASG?

Procaps Group has a beta of -0.05, suggesting that its stock price is 105% less volatile than the S&P 500. Comparatively, Passage Bio has a beta of 1.71, suggesting that its stock price is 71% more volatile than the S&P 500.

Does the MarketBeat Community prefer PROC or PASG?

Passage Bio received 50 more outperform votes than Procaps Group when rated by MarketBeat users. Likewise, 68.83% of users gave Passage Bio an outperform vote while only 37.50% of users gave Procaps Group an outperform vote.

Company	Underperform	Outperform
Procaps Group	Outperform Votes 3 37.50%	Underperform Votes 5 62.50%
Passage Bio	Outperform Votes 53 68.83%	Underperform Votes 24 31.17%

Does the media refer more to PROC or PASG?

In the previous week, Passage Bio had 1 more articles in the media than Procaps Group. MarketBeat recorded 1 mentions for Passage Bio and 0 mentions for Procaps Group. Passage Bio's average media sentiment score of 1.87 beat Procaps Group's score of 0.00 indicating that Passage Bio is being referred to more favorably in the news media.

Company	Overall Sentiment
Procaps Group	Neutral
Passage Bio	Very Positive

Summary

Passage Bio beats Procaps Group on 9 of the 14 factors compared between the two stocks.